Table 3 Safety-related adverse drug events among different ADCs
Drug names | ADC-associated gastrointestinal AEs as PSn (%) | ROR (95%CI) | PRR (95%CI) | χ2 |
|---|---|---|---|---|
BV | 137 | 5.79(4.86; 6.90) | 5.61(4.73; 6.64) | 486.06 |
EV | 209 | 3.26(2.82; 3.75) | 3.02(2.66; 3.43) | 295.56 |
GO | 22 | 7.87(5.13; 12.07) | 7.54(5.01; 11.34) | 119.03 |
IO | 30 | 11.12(7.71; 16.03) | 10.68(7.53; 15.16) | 254.45 |
MS | 54 | 4.37(3.28; 5.80) | 3.80(3.00; 4.81) | 120.00 |
PV | 80 | 6.47(5.16; 8.10) | 6.20(5.00; 7.67) | 345.72 |
SG | 183 | 5.19(4.44; 6.06) | 4.61(4.03; 5.267) | 528.25 |
TD | 764 | 4.22(3.91; 4.54) | 3.63(3.42; 3.86) | 1685.08 |
TE | 38 | 3.93(3.12; 4.95) | 3.85(3.08; 4.83) | 154.49 |